Test your research knowledge below.

All those who participate will be entered to win a $20 Amazon gift card.

True or false? MemorialCare was selected as one of the first five sites in the U.S. to participate in a Gilead study of the antiviral drug, Remdesivir, to treat severely ill hospitalized COVID-19 patients.
Incorrect Answer:

Try again.


 

Correct:

Long Beach Medical Center was selected by Gilead Sciences as one of the first expanded access sites on the West Coast to provide the investigational antiviral medication Remdesivir (RDV) as a treatment for COVID-19. In April 2020, Long Beach Medical Center enrolled its first three patients in the international, multicenter clinical study. The principal investigator on this study was Henry Su, M.D.


 

True or false? In 2020, MemorialCare had more than 600 subjects enrolled in clinical research studies, 306 of which were COVID-19 subjects.
Incorrect:

Try Again.


 

Correct:

645 subjects were enrolled. 306 of those subjects were enrolled in COVID-19 related studies. In 2020, the Research Program initiated 22 COVID-19 related trials, enrolling 306 COVID-19 patients, while guiding 16 COVID-19 studies through its pipeline.


 

How many active clinical trials does MemorialCare currently have?
Incorrect:

Try again.


 

Correct:

Our Research Program provides study opportunities over a broad range of specialty areas for both adult and pediatric patients across MemorialCare, including cancer, infectious disease, respiratory, heart/vascular, neuroscience, intensive care, maternal fetal, pharmacy, orthopedics and more.


 

How many active principal investigators does MemorialCare currently have?
Incorrect:

Try Again.


 

In 2020, how many new research studies were initiated at MemorialCare?
Incorrect:

Try Again.


 

Correct:

Our research studies would not be possible without the hard work of our clinical research team: 

  • Clinical Research Coordinators (CRCs): Kristina Alejo, Elysse Ballon, Daniel Blevins, Candice Evans, Ana Fuentes, Laura Macias, Kien Nguyen and Javier Zuniga
  • Regulatory Affairs Coordinators (RACs): Emillie Chisholm, Erica Felix, Pua Fineanganofo and Lisette Rosario-Remigio
  • Clinical Research Operations Managers: Michelle Kuan and Marylee Melendrez

     

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.